When did SANGAMO THERAPEUTICS INC (SGMO) report earnings last quarter?
SANGAMO THERAPEUTICS INC (SGMO) last reported earnings on 3/30/2026.
SANGAMO THERAPEUTICS INC (SGMO) Earnings History & Surprises
NASDAQ:SGMO • US8006771062
Current stock price
0.135 USD
+0.02 (+13.26%)
At close:
0.1314 USD
0 (-2.67%)
After Hours:
SGMO Earnings overview
Past quarterly earnings results for SANGAMO THERAPEUTICS INC (SGMO), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Earnings Snapshot
Next Earnings Date
Upcoming- Release Date
- May 18, 2026
- Period
- Q1 / 2026
- EPS Estimate
- $0.01
- Revenue Estimate
- 34.4M
Last Reported
Most Recent- Release Date
- Mar 30, 2026
- Period
- Q4 / 2025
- EPS Reported
- -$0.11
- EPS Surprise
- -79.74%
- Revenue Surprise
- -31.29%
Beat Rate
Last 8 Quarters 19%
EPS and Revenue beats vs estimates
Quarterly Earnings Historical Results
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | -0.11 | -0.06 | -79.74% | - | 14.228M | 20.706M | -31.29% | 88.43% |
| Q3 2025 | -0.11 | 0.00 | -63,537.14% | -375.00% | 581K | 35.088M | -98.34% | -98.82% |
| Q2 2025 | -0.08 | -0.13 | 38.49% | 55.56% | 18.306M | 32.314M | -43.35% | 5,042.13% |
| Q1 2025 | -0.14 | -0.13 | -5.04% | 48.15% | 6.437M | 7.565M | -14.91% | 1,238.25% |
| Q4 2024 | -0.11 | -0.09 | -18.18% | 67.65% | 7.551M | 13.889M | -45.63% | 269.78% |
| Q3 2024 | 0.04 | -0.03 | 237.26% | 106.78% | 49.412M | 18.302M | 169.98% | 425.77% |
| Q2 2024 | -0.18 | -0.15 | -21.11% | 72.73% | 356K | 8.425M | -95.77% | -94.79% |
| Q1 2024 | -0.27 | -0.22 | -23.84% | -325.00% | 481K | 6.788M | -92.91% | -99.70% |
| Q4 2023 | -0.34 | -0.26 | -30.10% | -6.25% | 2.042M | 8.267M | -75.30% | -92.49% |
| Q3 2023 | -0.59 | -0.33 | -80.76% | -73.53% | 9.398M | 10.613M | -11.45% | -64.54% |
| Q2 2023 | -0.66 | -0.35 | -88.94% | -127.59% | 6.835M | 15.129M | -54.82% | -76.75% |
| Q1 2023 | 0.12 | -0.33 | 135.85% | 140.00% | 157.957M | 24.546M | 543.51% | 460.13% |
| Q4 2022 | -0.32 | -0.37 | 12.85% | -23.08% | 27.2M | 27.394M | -0.71% | -2.86% |
| Q3 2022 | -0.34 | -0.36 | 6.22% | -3.03% | 26.5M | 27.321M | -3.01% | -7.34% |
| Q2 2022 | -0.29 | -0.36 | 19.40% | 12.12% | 29.4M | 25.123M | 17.02% | 5.38% |
| Q1 2022 | -0.30 | -0.32 | 5.43% | 6.25% | 28.2M | 27.831M | 1.33% | 7.22% |
| Q4 2021 | -0.26 | -0.35 | 26.21% | 10.34% | 28M | 27.36M | 2.34% | 8.53% |
| Q3 2021 | -0.33 | -0.34 | 4.00% | -3,200.00% | 28.6M | 25.693M | 11.31% | -50.52% |
| Q2 2021 | -0.33 | -0.32 | -3.45% | -26.92% | 27.9M | 27.014M | 3.28% | 29.17% |
| Q1 2021 | -0.32 | -0.30 | -6.84% | 13.51% | 26.3M | 25.146M | 4.59% | 100.76% |
| Q4 2020 | -0.29 | -0.22 | -33.65% | - | 25.8M | 32.795M | -21.33% | - |
| Q3 2020 | -0.01 | -0.25 | 95.95% | - | 57.8M | 27.08M | 113.44% | - |
| Q2 2020 | -0.26 | 0.07 | -464.15% | - | 21.6M | 104.76M | -79.38% | - |
| Q1 2020 | -0.37 | -0.29 | -26.67% | - | 13.1M | 23.191M | -43.51% | - |
Notes
- EPS and Revenue values are non-GAAP when available, otherwise GAAP.
- Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
- Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
- Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.
Earnings Q2Q Performance Trends
EPS Historical Q2Q growth and Acceleration
Revenue Historical Q2Q growth and Acceleration
Surprise distribution (Last 4 Quarters)
EPS beat statistics
EPS beat (4)
1
Average EPS beat (4)
-15,895.90%
Max EPS beat (4)
38.49%
Min EPS beat (4)
-63,537.10%
Revenue beat statistics
Revenue beat (4)
0
Average Revenue beat (4)
-46.97%
Max Revenue beat (4)
-14.91%
Min Revenue beat (4)
-98.34%
Analysis
In the last 4 quarters, SGMO has beaten EPS estimates in 1 out of 4 releases
SGMO has not beaten revenue estimates in any of the last 4 earnings releases
In the last 4 quarters, SGMO reported -15895.9% below the EPS estimates on average.
In the last 4 quarters, SGMO reported -47.0% below the revenue estimates on average.
Related analysis
SANGAMO THERAPEUTICS INC / SGMO Earnings FAQ
Did SGMO stock beat earnings estimates in the most recent quarter?
SANGAMO THERAPEUTICS INC (SGMO) missed EPS estimates and missed revenue estimates in the most recent quarter.
What percentage of the time does SGMO stock beat earnings estimates?
In the last 4 quarters, SANGAMO THERAPEUTICS INC (SGMO) has beaten EPS estimates in 1 out of 4 releases.